Pathology of a Canine Model of Localized Prostate Carcinoma
Authors:
Open Access
- 22 September 2025
- journal article
- Published by Wiley in The Prostate
- Vol. 86 (1) , 65-83
Abstract
Background: Dogs spontaneously develop prostate carcinoma (PC) and share prostate gland anatomy, physiology, and size to men. Over the last 15 years, we have developed and refined a canine model of focal PC to evaluate therapeutic‐diagnostic (theranostic) interventions. A comprehensive description of the pathology and synthesis of the various studies has not been performed. The goal of this manuscript was to describe the canine model tumor pathology within the framework of its methodological development to help guide future translational PC research. Methods: In published and unpublished studies, we previously inoculated prostate glands of immunosuppressed, intact beagle dogs ( n = 56) with a canine PC cell line (Ace‐1) transduced with human or canine genes for targeted theranostics. Gross tumor assessment and histology were performed in all cases. Molecular tumor and microenvironmental pathology was investigated using digital image analysis, immunohistochemistry, laser‐capture microdissection, and quantitative real‐time PCR. Results: The model reliably (85.7% engraftment rate) formed prostatic tumors resembling intermediate and high‐grade localized PC, with poorly differentiated morphology, stromal invasion, and peripheral growth. Soft tissue metastasis occurred in 13/48 (27.1%) dogs. Most dogs formed multifocal prostatic tumors with occasional tumors outside the prostate gland. Tumor location influenced growth behavior and the microenvironment. Allografts were histologically classified as intraglandular intraprostatic, invasive intraprostatic, capsular, or extraprostatic. Compared to intraprostatic tumors, capsular/extraprostatic tumors had increased proliferation (Ki‐67 index), epithelial‐to‐mesenchymal transition, and microenvironmental alterations that included increased collagenous stroma, fibroplasia, and reduced immune cell infiltration. Conclusions: The canine model of PC captured important pathologic features of men undergoing curative‐intent therapy alongside model‐ and species‐specific characteristics of interest to researchers. Beyond defining pathology, the results highlighted applications of the canine model in studying the tumor microenvironment and advancing preclinical, anti‐cancer strategies in a large animal species.Keywords
This publication has 68 references indexed in Scilit:
- Prostate CancerJAMA, 2025
- Active Surveillance or Watchful Waiting for Intermediate-Risk Prostate Cancer, 2010-2020JAMA, 2024
- Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate CancerJAMA, 2024
- Alterations of C‐MYC, NKX3.1, and E‐cadherin expression in canine prostate carcinogenesisMicroscopy Research and Technique, 2013
- A novel canine model for prostate cancerThe Prostate, 2013
- Refining the orthotopic dog prostate cancer (DPC)‐1 model to better bridge the gap between rodents and menThe Prostate, 2011
- Dickkopf‐1 (DKK‐1) stimulated prostate cancer growth and metastasis and inhibited bone formation in osteoblastic bone metastasesThe Prostate, 2010
- Comparative characterization of the canine normal prostate in intact and castrated animalsThe Prostate, 2008
- New bone formation and osteolysis by a metastatic, highly invasive canine prostate carcinoma xenograftThe Prostate, 2006
- Prostatic Intra-Epithelial Neoplasia and Early Invasion in Prostate CancerCancer, 1987